Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes
Dan Dong, Tingting Fan, Yingshi Ji, et al.
International Urology and Nephrology (2019) Vol. 51, Iss. 4, pp. 755-764
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects
Jonatan Barrera‐Chimal, Ixchel Lima‐Posada, George L. Bakris, et al.
Nature Reviews Nephrology (2021) Vol. 18, Iss. 1, pp. 56-70
Closed Access | Times Cited: 155
Renin-angiotensin-aldosterone system and COVID-19 infection
Joachim Alexandre, Jean‐Luc Cracowski, Vincent Richard, et al.
Annales d Endocrinologie (2020) Vol. 81, Iss. 2-3, pp. 63-67
Open Access | Times Cited: 81
Revisiting Experimental Models of Diabetic Nephropathy
Anna Giralt-López, Mireia Molina-Van den Bosch, Ander Vergara, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3587-3587
Open Access | Times Cited: 73
Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects
Xiandeng Li, Ying Zhang, Xiaodong Xing, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115670-115670
Open Access | Times Cited: 41
Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease
Dong‐Lim Kim, Seung‐Eun Lee, Nan Hee Kim
Endocrinology and Metabolism (2023) Vol. 38, Iss. 1, pp. 43-55
Open Access | Times Cited: 27
Mitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets
Nadezda Apostolova, Teresa Vezza, Jordi Muntané, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 4-6, pp. 278-320
Closed Access | Times Cited: 23
Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2
Morag J. Young, Colin D. Clyne, Karen E. Chapman
Journal of Endocrinology (2020) Vol. 247, Iss. 2, pp. R45-R62
Open Access | Times Cited: 59
Role of mineralocorticoid receptor antagonists in kidney diseases
Vishal Patel, Amit Joharapurkar, Mukul R. Jain
Drug Development Research (2020) Vol. 82, Iss. 3, pp. 341-363
Closed Access | Times Cited: 50
The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy
Jun Sun
Medical Hypotheses (2020) Vol. 143, pp. 110083-110083
Open Access | Times Cited: 41
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
Murat Öz, Dietrich E. Lorke, Nadine Kabbani
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107750-107750
Open Access | Times Cited: 41
Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease
Toshifumi Nakamura, Sophie Girerd, Frédéric Jaisser, et al.
Kidney International Supplements (2022) Vol. 12, Iss. 1, pp. 12-18
Open Access | Times Cited: 26
A Randomized Trial of Sitagliptin and Spironolactone With Combination Therapy in Hospitalized Adults With COVID-19
Farhad Abbasi, Reuben Adatorwovor, Mohammad Ali Davarpanah, et al.
Journal of the Endocrine Society (2022) Vol. 6, Iss. 4
Open Access | Times Cited: 23
Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction
Ixchel Lima‐Posada, Yohan Stephan, Matthieu Soulié, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2536-2536
Open Access | Times Cited: 14
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
Daiji Kawanami, Yuichi Takashi, Yoshimi Muta, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 32
The mineralocorticoid receptor in chronic kidney disease
Jonatan Barrera‐Chimal, Frédéric Jaisser, Hans‐Joachim Anders
British Journal of Pharmacology (2021) Vol. 179, Iss. 13, pp. 3152-3164
Open Access | Times Cited: 26
Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review
Kamyar Asadipooya, Artin Asadipooya, Reuben Adatorwovor
Archives of Virology (2024) Vol. 169, Iss. 6
Closed Access | Times Cited: 3
Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review
Hajira Dambha‐Miller, Ali Albasri, Sam Hodgson, et al.
BMJ Open (2020) Vol. 10, Iss. 9, pp. e040644-e040644
Open Access | Times Cited: 27
Oil-In-Water Microemulsion Encapsulation of Antagonist Drugs Prevents Renal Ischemia-Reperfusion Injury in Rats
Parisa Hasanein, Abbas Rahdar, Mahmood Barani, et al.
Applied Sciences (2021) Vol. 11, Iss. 3, pp. 1264-1264
Open Access | Times Cited: 21
Lysosome Depletion-Triggered Autophagy Impairment in Progressive Kidney Injury
Xiaocui Chen, Zhihang Li, Chen Yang, et al.
Kidney Diseases (2021) Vol. 7, Iss. 4, pp. 254-267
Open Access | Times Cited: 21
Autophagy and Diabetic Nephropathy
Jing Cui, Xueyuan Bai, Xiangmei Chen
Advances in experimental medicine and biology (2020), pp. 487-494
Closed Access | Times Cited: 23
Autophagy and podocytopathy
Claudio Ponticelli, Gabriella Moroni, Francesco Reggiani
Nephrology Dialysis Transplantation (2023) Vol. 38, Iss. 9, pp. 1931-1939
Closed Access | Times Cited: 7
Mineralocorticoid Receptor Antagonism Prevents the Synergistic Effect of Metabolic Challenge and Chronic Kidney Disease on Renal Fibrosis and Inflammation in Mice
Roberto Palacios, Ixchel Lima‐Posada, Benjamin Bonnard, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 12
Rediscovery of the implication of albuminuria in heart failure: emerging classic index for cardiorenal interaction
Kyung‐Duk Min, Yuki Matsumoto, Masanori Asakura, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 6, pp. 3470-3487
Open Access | Times Cited: 2
The Mineralocorticoid Receptors in diabetic kidney disease
Guanghong Jia, Guido Lastra, Brian P. Bostick, et al.
AJP Renal Physiology (2024) Vol. 327, Iss. 3, pp. F519-F531
Closed Access | Times Cited: 2
Metainflammation in COVID-19
Mojtaba Bakhtiari, Kamyar Asadipooya
Endocrine Metabolic & Immune Disorders - Drug Targets (2022) Vol. 22, Iss. 12, pp. 1154-1166
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top